.png){kind=icon}
返回
Chagas disease
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(23)01787-7.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Chagas disease persists as a global public health problem due to the high morbidity and mortality burden. Despite the possibility of a cure and advances in transmission control, epidemiological transformations, such as urbanisation and globalisation, and the emerging importance of oral and vertical transmission mean that Chagas disease should be considered an emerging disease, with new cases occurring worldwide. Important barriers to diagnosis, treatment, and care remain, resulting in repressed numbers of reported cases, which in turn leads to inadequate public policies. The validation of new diagnostic tools and treatment options is needed, as existing tools pose serious limitations to access to health care. Integrated models of surveillance, with community and intersectional participation, embedded in the concept of One Health, are essential for control. In addition, mitigation strategies for the main social determinants of health, including difficulties imposed by migration, are important to improve access to comprehensive health care in a globalised scenario.
Keyword:
ORGAN TRANSPLANT RECIPIENTS
TRYPANOSOMA-CRUZI INFECTION
CONGENITAL CHAGAS
RANDOMIZED-TRIAL
BENZNIDAZOLE
RECOMMENDATIONS
TRANSMISSION
PREVENTION
MANAGEMENT
WOMEN
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
Trypanosoma cruzi transmission in the wild and its most important reservoir hosts in Brazil.png)
PARASITES & VECTORS
OAAI
PARASITES & VECTORSIF3.5
OAAI分享收藏分享收藏Global, Regional, and National Trends of Chagas Disease from 1990 to 2019: Comprehensive Analysis of the Global Burden of Disease StudyGLOBAL HEARTOAAI
GLOBAL HEARTIF3.1
OAAI分享收藏
查看更多内容